Disease Areas of
Collaborative Focus


Cancer Supportive Care

BioModels is internationally recognized for its groundbreaking work in oral mucositis. Additional models have also been developed to address unmet needs for the toxicities associated with treatment of diverse cancers. With the dramatic improvement in the survivorship of cancer patients, increased resources have been applied to the development of new drugs and therapeutics for the complications associated with cancer treatment.

Work with BioModels to:

  • Evaluate experimental materials for efficacy in models of proctitis, fatigue, dermatitis, hemostasis, myelosuppression, neurological toxicity, and more.
  • Determine target engagement and mechanism of action in models that recapitulate complex mechanisms.
  • Customize or develop models most suitable for your needs.

Daniel Lichtman

Managing Partner